Active Ingredient: AMLODIPINE BENZOATE
Proprietary Name: KATERZIA
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: EQ 1MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211340
Product Number: 001
Approval Date: Jul 8, 2019
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
